Investment Analysts’ Updated EPS Estimates for July 23rd (AGYS, AMZN, ARE, BOKF, BXMT, CADE, CALX, CDNS, CNC, CRWD)

Investment Analysts’ updated eps estimates for Tuesday, July 23rd:

Agilysys (NASDAQ:AGYS) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $125.00 price target on the stock.

Amazon.com (NASDAQ:AMZN) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $225.00 price target on the stock.

Alexandria Real Estate Equities (NYSE:ARE) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $140.00 price target on the stock.

BOK Financial (NASDAQ:BOKF) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $104.00 price target on the stock.

Blackstone Mortgage Trust (NYSE:BXMT) had its market perform rating reiterated by analysts at JMP Securities.

Cadence Bank (NYSE:CADE) had its overweight rating reissued by analysts at Stephens. They currently have a $35.00 price target on the stock.

Calix (NYSE:CALX) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $45.00 target price on the stock.

Cadence Design Systems (NASDAQ:CDNS) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $320.00 price target on the stock.

Centene (NYSE:CNC) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $90.00 price target on the stock.

CrowdStrike (NASDAQ:CRWD) had its hold rating reissued by analysts at Westpark Capital.

CVS Health (NYSE:CVS) had its neutral rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $58.00 price target on the stock.

DoubleVerify (NYSE:DV) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $33.00 target price on the stock.

DexCom (NASDAQ:DXCM) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $145.00 price target on the stock.

Elevance Health (NYSE:ELV) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $600.00 price target on the stock.

Vertical Aerospace (NYSE:EVTL) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $1.50 price target on the stock.

Globant (NYSE:GLOB) had its overweight rating reiterated by analysts at Piper Sandler. They currently have a $238.00 price target on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $210.00 target price on the stock.

Gold Royalty (NYSE:GROY) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $5.75 target price on the stock.

HBT Financial (NASDAQ:HBT) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $27.00 price target on the stock, up from their previous price target of $25.00.

Humana (NYSE:HUM) had its neutral rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $360.00 target price on the stock.

Inter Parfums (NASDAQ:IPAR) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $151.00 price target on the stock, up from their previous price target of $150.00.

Metropolitan Bank (NYSE:MCB) had its outperform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $67.50 target price on the stock, up from their previous target price of $55.00.

MetroCity Bankshares (NASDAQ:MCBS) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $32.00 price target on the stock, up from their previous price target of $28.00.

Madrigal Pharmaceuticals (NASDAQ:MDGL) had its neutral rating reiterated by analysts at Cantor Fitzgerald.

Medpace (NASDAQ:MEDP) had its outperform rating reissued by analysts at William Blair.

Molina Healthcare (NYSE:MOH) had its overweight rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $406.00 price target on the stock.

Microsoft (NASDAQ:MSFT) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $485.00 price target on the stock, up from their previous price target of $465.00.

NBT Bancorp (NASDAQ:NBTB) had its overweight rating reiterated by analysts at Stephens. They currently have a $42.00 price target on the stock.

ServiceNow (NYSE:NOW) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. They currently have a $835.00 target price on the stock.

NXP Semiconductors (NASDAQ:NXPI) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $350.00 price target on the stock.

Nexstar Media Group (NASDAQ:NXST) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $200.00 price target on the stock.

Insulet (NASDAQ:PODD) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $234.00 price target on the stock.

RAPT Therapeutics (NASDAQ:RAPT) had its neutral rating reiterated by analysts at HC Wainwright.

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $111.00 price target on the stock.

RBB Bancorp (NASDAQ:RBB) had its equal weight rating reiterated by analysts at Stephens. The firm currently has a $20.00 target price on the stock.

RLI (NYSE:RLI) had its market perform rating reiterated by analysts at JMP Securities.

Selective Insurance Group (NASDAQ:SIGI) had its market perform rating reaffirmed by analysts at JMP Securities.

SmartFinancial (NASDAQ:SMBK) had its overweight rating reissued by analysts at Stephens. The firm currently has a $27.00 target price on the stock.

Southern States Bancshares (NASDAQ:SSBK) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $36.00 price target on the stock, up from their previous price target of $35.00.

Taysha Gene Therapies (NASDAQ:TSHA) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $7.00 price target on the stock.

Tesla (NASDAQ:TSLA) had its sell rating reiterated by analysts at Guggenheim. The firm currently has a $134.00 target price on the stock.

UnitedHealth Group (NYSE:UNH) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $591.00 target price on the stock.

Verizon Communications (NYSE:VZ) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $42.00 target price on the stock.

Warner Bros. Discovery (NASDAQ:WBD) had its outperform rating reiterated by analysts at Barrington Research. They currently have a $12.00 price target on the stock.

W. R. Berkley (NYSE:WRB) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $57.00 target price on the stock.

Xometry (NASDAQ:XMTR) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $27.00 price target on the stock.